journal article·2025-09

Reprogrammed glycolysis-induced augmentation of NIR-II excited photodynamic/photothermal therapy

Chunbai Xiang, Qihang Ding, Ting Jiang, Yu Liu, Chao Li, Xing Yang, Jia Jia, Jingjing Xiang, Yue Wang, Hui Zhou, Zhiyun Lu, Ping Gong, Jong Seung Kim

Biomaterials· Volume 320
Publisher page

Abstract

Small molecule-based multifunctional optical diagnostic materials have garnered considerable interest due to their highly customizable structures, tunable excited-state properties, and remarkable biocompatibility. We herein report the synthesis of a multifaceted photosensitizer, PPQ-CTPA, which exhibits exceptional efficacy in generating Type I reactive oxygen species (ROS) and thermal energy under near-infrared-II (NIR-II, >1000 nm) laser excitation at 1064 nm, thereby combining photodynamic therapy (PDT) and photothermal therapy (PTT) functionalities. To enhance therapeutic efficacy, we engineered lonidamine (LND) by conjugating it with triphenylphosphonium (TPP) cations, producing LND-TPP. This compound inhibits mitochondrial glycolysis and downregulates heat shock protein 90 (HSP 90) levels in a breast cancer mouse model, potentiating both PDT and PTT. For in vivo applications, PPQ-CTPA and LND-TPP are encapsulated within the amphiphilic polymer DSPE-SS-PEG to obtain PPQ-CTPAL NPs. In breast cancer cell lines, PPQ-CTPAL NPs are decomposed by cellular GSH, simultaneously releasing the dual-functioning photosensitizer PPQ-CTPL and the mitochondria-disrupting agent LND-TPP. Upon 1064 nm laser irradiation, we found that tumor growth in breast cancer mice is effectively restrained by PPQ-CTPAL NPs. This work highlights the synergistic integration of PDT, PTT, and chemotherapy facilitated by NIR-II fluorescence, photoacoustic, and photothermal imaging under 1064 nm irradiation, underscoring the clinical potential of multifunctional phototherapeutic agents.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (68)

Show source-provided references
1. Improving image-guided surgical and immunological tumor treatment efficacy by photothermal and photodynamic therapies based on a multifunctional NIR AIEgen10.1002/adma.202101158 ↗
2. Design of superior phototheranostic agents guided by Jablonski diagrams10.1039/D0CS00671H ↗
3. Theranostic fluorescent probes10.1021/acs.chemrev.3c00778 ↗
4. Phototherapeutic nanoagents for cancer immunotherapy10.1016/j.pmatsci.2024.101347 ↗
5. Oxygen-independent organic photosensitizer with ultralow-power NIR photoexcitation for tumor-specific photodynamic therapy10.1038/s41467-024-46768-w ↗
6. Augmenting cancer therapy with a supramolecular immunogenic cell death inducer: a lysosome-targeted NIR-light-activated ruthenium(II) metallacycle10.1021/jacs.3c13224 ↗
7. Blending low-frequency vibrations and push–pull effects affords superior photoacoustic imaging agents10.1002/anie.202307797 ↗
8. W. Liu, S. He, X. Ma, C. Lv, H. Gu, J. Cao, J. Du, W. Sun, J. Fan, X. Peng, Near–infrared heptamethine cyanine photosensitizers with efficient singlet oxygen generation for anticancer photodynamic therapy, Angewandte Chemie International Edition n/a(n/a) e202411802.
9. Recent advances in the design and applications of near-infrared II responsive small molecule phototherapeutic agents10.1016/j.ccr.2024.215677 ↗
10. Fluorescent porous materials based on aggregation-induced emission for biomedical applications10.1021/acsnano.4c08882 ↗
11. An activatable phototheranostic probe for anti-hypoxic type I photodynamic- and immuno-therapy of cancer10.1002/adma.202305243 ↗
12. Achieving efficient NIR-II type-I photosensitizers for photodynamic/photothermal therapy upon regulating chalcogen elements10.1002/adma.202108146 ↗
13. Y.-Y. Zhao, X. Zhang, Y. Xu, Z. Chen, B. Hwang, H. Kim, H. Liu, X. Li, J. Yoon, A renal clearable nano-assembly with förster resonance energy transfer amplified superoxide radical and heat generation to overcome hypoxia resistance in phototherapeutics, Angewandte Chemie International Edition n/a(n/a) e202411514.
14. Deciphering oxygen-independent augmented photodynamic oncotherapy by facilitating the separation of electron-hole pairs10.1002/anie.202401036 ↗
15. Trisulfide bond-mediated molecular phototheranostic platform for “activatable” NIR-II imaging-guided enhanced gas/chemo-hypothermal photothermal therapy10.1002/advs.202304104 ↗
16. H2O2-Responsive NIR-II AIE nanobomb for carbon monoxide boosting low-temperature photothermal therapy10.1002/anie.202207213 ↗
17. Strategies for efficient photothermal therapy at mild temperatures: progresses and challenges10.1016/j.cclet.2021.08.023 ↗
18. G. Fan, S. Hou, Y. Gu, H. Jiang, W. Zhang, W. Wu, M. Wang, L. Tian, NIR-II emissive oligonucleotides grafted π-conjugated polymers for low-temperature photothermal and gene combined therapy, Angewandte Chemie International Edition n/a(n/a) e202425654.
19. Rationally manipulating molecular planarity to improve molar absorptivity, NIR-II brightness, and photothermal effect for tumor phototheranostics10.1016/j.biomaterials.2025.123113 ↗
20. G. Ma, Q. Ding, Y. Wang, Z. Zhang, Y. Zhang, H. Shi, L. Cai, P. Gong, P. Zhang, Z. Cheng, J.S. Kim, Precision photothermal therapy at mild temperature: NIR-II imaging-guided, H2O2-responsive stealth nanobomb, Advanced Healthcare Materials n/a(n/a) 2402767.
21. NIR-II responsive inorganic 2D nanomaterials for cancer photothermal therapy: recent advances and future challenges10.1002/adfm.202101625 ↗
22. Near-infrared-II nanomaterials for fluorescence imaging and photodynamic therapy10.1002/adom.202002177 ↗
23. Crucial breakthrough of second near-infrared biological window fluorophores: design and synthesis toward multimodal imaging and theranostics10.1039/C8CS00234G ↗
24. Supramolecular materials based on AIEgens for photo-assisted therapy10.1016/j.biomaterials.2022.121595 ↗
25. RNA-activatable near-infrared photosensitizer for cancer therapy10.1021/jacs.4c09470 ↗
26. Diverse interactions between AIEgens and biomolecules/organisms: advancing from strategic design to precision theranostics10.1016/j.chempr.2024.06.018 ↗
27. Near-infrared-absorbing B–N lewis pair-functionalized anthracenes: electronic structure tuning, conformational isomerism, and applications in photothermal cancer therapy10.1021/jacs.2c06538 ↗
28. Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy10.1039/D2CS00722C ↗
29. NIR-II excitation phototheranostic platform for synergistic photothermal therapy/chemotherapy/chemodynamic therapy of breast cancer bone metastases10.1002/advs.202204718 ↗
30. Furan-modified thiadiazolo quinoxaline as an electron acceptor for constructing second near-infrared aggregation-induced emission fluorophores for beyond 1300 nm fluorescence/photoacoustic imaging and photothermal therapy10.1002/agt2.458 ↗
31. Acceptor engineering for NIR-II dyes with high photochemical and biomedical performance10.1038/s41467-022-31521-y ↗
32. Benzobisthiadiazole-alt-bithiazole copolymers with deep HOMO levels for good-performance field-effect transistors with air stability and a high on/off ratio10.1039/C6PY00212A ↗
33. Novel NIR-II organic fluorophores for bioimaging beyond 1550 nm10.1039/C9SC06567A ↗
34. A borondifluoride-complex-based photothermal agent with an 80 % photothermal conversion efficiency for photothermal therapy in the NIR-II window10.1002/anie.202107836 ↗
35. Rational design of conjugated small molecules for superior photothermal theranostics in the NIR-II biowindow10.1002/adma.202001146 ↗
36. Shi · 2023 · vol. 6 · 169
37. A gas/phototheranostic nanocomposite integrates NIR-II-peak absorbing aza-BODIPY with thermal-sensitive nitric oxide donor for atraumatic osteosarcoma therapy
38. A nanographene-porphyrin hybrid for near-infrared-ii phototheranostics10.1002/advs.202309131 ↗
39. Self-assembled organic nanomedicine enables ultrastable photo-to-heat converting theranostics in the second near-infrared biowindow10.1038/s41467-020-20566-6 ↗
40. A terrylene–anthraquinone dyad as a chromophore for photothermal therapy in the NIR-II window10.1021/jacs.3c11314 ↗
41. Fused azulenyl squaraine derivatives improve phototheranostics in the second near-infrared window by concentrating excited state energy on non-radiative decay pathways10.1002/anie.202400372 ↗
42. An all-rounder for NIR-II phototheranostics: well-tailored 1064 nm-excitable molecule for photothermal combating of orthotopic breast cancer10.1002/anie.202401877 ↗
43. BF2-Bridged azafulvene dimer-based 1064 nm laser-driven superior photothermal agent for deep-seated tumor therapy10.1002/anie.202407307 ↗
44. P. Chen, J. Rong, K. Chen, T. Huang, Q. Shen, p. sun, W. Tang, Q. Fan, Photo-amplified plasma membrane rupture by membrane-anchoring NIR-II small molecule design for improved cancer photoimmunotherapy, Angewandte Chemie International Edition n/a(n/a) e202418081.
45. An NIR-II excitable AIE small molecule with multimodal phototheranostic features for orthotopic breast cancer treatment10.1002/adma.202309748 ↗
46. The mitochondrial retrograde signaling regulates Wnt signaling to promote tumorigenesis in colon cancer10.1038/s41418-018-0265-6 ↗
47. Mitochondrial ATP generation is more proteome efficient than glycolysis10.1038/s41589-024-01571-y ↗
48. Metabolic intervention liposome for targeting glutamine-addiction of breast cancer10.1016/j.jconrel.2022.07.034 ↗
49. The therapeutic potential of targeting hsp90-cdc37 interactions in several diseases10.2174/1389450123666220408101544 ↗
50. Membrane-anchored heat-shock protein 70 (Hsp70) in cancer10.1016/j.canlet.2019.10.037 ↗
51. Y. Xu, H. Dang, C. Teng, D. Yin, L. Yan, ATP inhibition for starvation/mild photothermal/photodynamic synergy therapy using polypeptide nanoparticles conjugating 2-deoxy-D-glucose and dye under NIR phototheranostic strategy, Advanced Healthcare Materials n/a(n/a) 2401219.
52. Lonidamine liposomes to enhance photodynamic and photothermal therapy of hepatocellular carcinoma by inhibiting glycolysis10.1186/s12951-023-02260-z ↗
53. Multifunctional liquid metal-based nanoparticles with glycolysis and mitochondrial metabolism inhibition for tumor photothermal therapy10.1016/j.biomaterials.2022.121369 ↗
54. Tumor metabolism destruction via metformin-based glycolysis inhibition and glucose oxidase-mediated glucose deprivation for enhanced cancer therapy10.1016/j.actbio.2022.04.022 ↗
55. A mitochondria-targeting self-assembled carrier-free lonidamine nanodrug for redox-activated drug release to enhance cancer chemotherapy10.1039/D2TB02728C ↗
56. GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells10.1038/s41388-022-02506-4 ↗
57. Metformin-associated lactic acidosis and acute kidney injury in the era of COVID-19
58. Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer10.1186/s13045-018-0577-5 ↗
59. Tumor selective metabolic reprogramming as a prospective PD-L1 depression strategy to reactivate immunotherapy10.1002/adma.202206121 ↗
60. A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism10.1016/j.phrs.2023.106740 ↗
61. Triple enzyme-regulated molecular hydrogels for carrier-free delivery of lonidamine10.1002/adfm.202104418 ↗
62. Dual Channel activatable cyanine dye for mitochondrial imaging and mitochondria-targeted cancer theranostics10.1021/acsbiomaterials.7b00480 ↗
63. A cyanine with 83.2% photothermal conversion efficiency and absorption wavelengths over 1200 nm for photothermal therapy10.1002/adhm.202304421 ↗
64. Multiwfn: a multifunctional wavefunction analyzer10.1002/jcc.22885 ↗
65. Software update: the ORCA program system—version 5.010.1002/wcms.1606 ↗
66. The ORCA quantum chemistry program package10.1063/5.0004608 ↗
67. 9,10-Phenanthrenequinone: a promising kernel to develop multifunctional antitumor systems for efficient type I photodynamic and photothermal synergistic therapy10.1021/acsnano.1c07730 ↗
68. Electrostatic potential of the incorporated asymmetry molecules induced high charge separation efficiency of the modified carbon nitride copolymers10.1016/j.apcatb.2022.121922 ↗